F-group (family)
2002.1.1.263 IMPDH, FMN_dh
Ligands and drugs
356
Member domains
218
with ligand contacts (≤ 4 Å)
61.2% of members
110
with DrugDomain annotations
30.9% of members
108
with a DrugBank compound
30.3% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 2002.1.1.263 belongs to X-group 2002 TIM beta/alpha-barrel, which binds 8.7 ligand superclasses per 20 proteins, broader than 71% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB04566 | IMP | Inosinic Acid | 85 |
| DB14128 | NAD | Nadide | 12 |
| DB04137 | GTP | Guanosine-5'-Triphosphate | 9 |
| DB01972 | 5GP | Guanosine-5'-Monophosphate | 7 |
| DB04315 | GDP | Guanosine-5'-Diphosphate | 7 |
| DB01024 | MOA | Mycophenolic acid | 3 |
| DB02309 | XMP | 5-monophosphate-9-beta-D-ribofuranosyl xanthine | 3 |
| DB03247 | FMN | Flavin mononucleotide | 2 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| IMP | INOSINIC ACID | 161 |
| Kmetal | POTASSIUM ION | 80 |
| NAD | NICOTINAMIDE-ADENINE-DINUCLEOTIDE | 26 |
| GTP | GUANOSINE-5'-TRIPHOSPHATE | 25 |
| G4P | GUANOSINE-5',3'-TETRAPHOSPHATE | 16 |
| CL | CHLORIDE ION | 11 |
| A1AG0 | 9-{(1R)-1-[(5P)-5-(4-chloro-1H-imidazol-2-yl)pyridin-3-yl]ethoxy}-1,4-dihydro-2H-pyrano[3,4-c]quinoline | 9 |
| VOA | N-(6-chloropyridin-3-yl)-N~2~-(1,4-dihydro-2H-pyrano[3,4-c]quinolin-9-yl)-L-alaninamide | 9 |
| VP4 | N-[4-chloro-3-(dimethylamino)phenyl]-N~2~-[3-(hydroxymethyl)quinolin-6-yl]-L-alaninamide | 9 |
| 8L1 | N-{4-chloro-3-[4-(trifluoromethyl)-1,3-thiazol-2-yl]phenyl}-N'-(2-{3-[(1E)-N-hydroxyethanimidoyl]phenyl}propan-2-yl)urea | 8 |
| 8L4 | 3-(2-{[(4-chlorophenyl)carbamoyl]amino}propan-2-yl)-N-hydroxybenzene-1-carboximidamide | 8 |
| 8L7 | N-{2-chloro-5-[({2-[3-(prop-1-en-2-yl)phenyl]propan-2-yl}carbamoyl)amino]phenyl}-alpha-D-ribofuranosylamine | 8 |
| A1AUF | N-[4-chloro-3-(morpholin-4-yl)phenyl]-N~2~-[3-(hydroxymethyl)quinolin-6-yl]-L-alaninamide | 8 |
| 5GP | GUANOSINE-5'-MONOPHOSPHATE | 7 |
| GDP | GUANOSINE-5'-DIPHOSPHATE | 7 |
| C64 | N-(4-bromophenyl)-2-[2-(1,3-thiazol-2-yl)-1H-benzimidazol-1-yl]acetamide | 6 |
| Q21 | (2S)-2-(naphthalen-1-yloxy)-N-[2-(pyridin-4-yl)-1,3-benzoxazol-5-yl]propanamide | 6 |
| JQS | 5-[(Z)-(aminomethylidene)amino]-1-(5-O-phosphono-beta-D-ribofuranosyl)-1H-imidazole-4-carboxylic acid | 5 |
| C91 | N-(naphthalen-2-yl)-2-[2-(pyridin-2-yl)-1H-benzimidazol-1-yl]acetamide | 4 |
| I13 | 1-(2-{3-[(1E)-N-(2-aminoethoxy)ethanimidoyl]phenyl}propan-2-yl)-3-(4-chloro-3-nitrophenyl)urea | 4 |